Tag: flu vaccine business
CSL acquires Novartis flu division
CSL is set to become the second largest flu vaccine business in the world with the acquisition of a subsidiary of Swiss pharmaceutical multinational...
Featured Article
Australian Manufacturing Week 2026 enters final run-up to Brisbane debut
Australia’s manufacturing sector continues to play a critical role in the national economy, underpinned by ongoing investment in advanced technologies, automation, and high-value production.
